Evidence map›Paper›PMID 35077453›Full record

SynthesisPLoS medicine2022

Ruling out pulmonary embolism across different healthcare settings: A systematic review and individual patient data meta-analysis.

Geert-Jan Geersing, Toshihiko Takada, Frederikus A Klok, Harry R Büller, D Mark Courtney, Yonathan Freund, Javier Galipienzo, Gregoire Le Gal, Waleed Ghanima, Jeffrey A Kline and 13 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in PLoS medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Observational
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Reducing the global burden of cerebral venous thrombosis: An international research agenda.International journal of stroke : official journal of the International Stroke Society · 2024
    Review
  13. The History of Diagnosing Venous Thromboembolism.Seminars in thrombosis and hemostasis · 2024
    Review
  14. Article
  15. Sex differences in guideline-consistent diagnostic testing for acute pulmonary embolism among adult emergency department patients aged 18-49.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Risk Scores in Venous Thromboembolism Guidelines of ESC, ACCP, and ASH: An Updated Review.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Geert-Jan GeersingJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.ORCID 0000-0001-6976-9844
Toshihiko TakadaJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Frederikus A KlokDepartment of Medicine, Thrombosis and Haemostasis, Dutch Thrombosis Network, Leiden University Medical Center, Leiden, the Netherlands.ORCID 0000-0001-9961-0754
Harry R BüllerDepartment of Medicine, Amsterdam University Medical Center, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
D Mark CourtneyDepartment of Emergency Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
Yonathan FreundSorbonne University, Emergency Department, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
Javier GalipienzoService of Anesthesiology, MD Anderson Cancer Center Madrid, Madrid, Spain.ORCID 0000-0002-8300-6568
Gregoire Le GalDepartment of Medicine, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Canada.
Waleed GhanimaDepartment of Medicine, Østfold Hospital Trust, Norway and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Jeffrey A KlineDepartment of Emergency Medicine, Wayne State School of Medicine, Detroit, Michigan, United States of America.ORCID 0000-0001-7190-3109
Menno V HuismanDepartment of Medicine, Thrombosis and Haemostasis, Dutch Thrombosis Network, Leiden University Medical Center, Leiden, the Netherlands.
Karel G M MoonsJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Arnaud PerrierDivision of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.ORCID 0000-0001-5549-8609
Sameer ParpiaDepartment of Oncology, McMaster University, Hamilton, Canada.ORCID 0000-0002-9407-5622
Helia Robert-EbadiDivision of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
Marc RighiniDivision of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
Pierre-Marie RoyUNIV Angers, UMR (CNRS 6015-INSERM 1083) and CHU Angers, Department of Emergency Medicine, F-CRIN InnoVTE, Angers, France.
Maarten van SmedenJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.ORCID 0000-0002-5529-1541
Milou A M StalsDepartment of Medicine, Thrombosis and Haemostasis, Dutch Thrombosis Network, Leiden University Medical Center, Leiden, the Netherlands.ORCID 0000-0003-2328-7705
Philip S WellsDepartment of Medicine, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Canada.ORCID 0000-0002-8657-8326
Kerstin de WitDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.ORCID 0000-0003-2763-6474
Noémie KraaijpoelDepartment of Medicine, Amsterdam University Medical Center, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.ORCID 0000-0002-1124-695X
Nick van EsDepartment of Medicine, Amsterdam University Medical Center, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.ORCID 0000-0001-5256-6346

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe challenging clinical dilemma of detecting pulmonary embolism (PE) in suspected patients is encountered in a variety of healthcare settings. We hypothesized that the optimal diagnostic approach to detect these patients in terms of safety and efficiency depends on underlying PE prevalence, case mix, and physician experience, overall reflected by the type of setting where patients are initially assessed. The objective of this study was to assess the capability of ruling out PE by available diagnostic strategies across all possible settings. METHODS AND

findingsWe performed a literature search (MEDLINE) followed by an individual patient data (IPD) meta-analysis (MA; 23 studies), including patients from self-referral emergency care (n = 12,612), primary healthcare clinics (n = 3,174), referred secondary care (n = 17,052), and hospitalized or nursing home patients (n = 2,410). Multilevel logistic regression was performed to evaluate diagnostic performance of the Wells and revised Geneva rules, both using fixed and adapted D-dimer thresholds to age or pretest probability (PTP), for the YEARS algorithm and for the Pulmonary Embolism Rule-out Criteria (PERC). All strategies were tested separately in each healthcare setting. Following studies done in this field, the primary diagnostic metrices estimated from the models were the "failure rate" of each strategy-i.e., the proportion of missed PE among patients categorized as "PE excluded" and "efficiency"-defined as the proportion of patients categorized as "PE excluded" among all patients. In self-referral emergency care, the PERC algorithm excludes PE in 21% of suspected patients at a failure rate of 1.12% (95% confidence interval [CI] 0.74 to 1.70), whereas this increases to 6.01% (4.09 to 8.75) in referred patients to secondary care at an efficiency of 10%. In patients from primary healthcare and those referred to secondary care, strategies adjusting D-dimer to PTP are the most efficient (range: 43% to 62%) at a failure rate ranging between 0.25% and 3.06%, with higher failure rates observed in patients referred to secondary care. For this latter setting, strategies adjusting D-dimer to age are associated with a lower failure rate ranging between 0.65% and 0.81%, yet are also less efficient (range: 33% and 35%). For all strategies, failure rates are highest in hospitalized or nursing home patients, ranging between 1.68% and 5.13%, at an efficiency ranging between 15% and 30%. The main limitation of the primary analyses was that the diagnostic performance of each strategy was compared in different sets of studies since the availability of items used in each diagnostic strategy differed across included studies; however, sensitivity analyses suggested that the findings were robust.

conclusionsThe capability of safely and efficiently ruling out PE of available diagnostic strategies differs for different healthcare settings. The findings of this IPD MA help in determining the optimum diagnostic strategies for ruling out PE per healthcare setting, balancing the trade-off between failure rate and efficiency of each strategy.

Indexed as

Data Interpretation, StatisticalDelivery of Health CareHumansPulmonary Embolism

Identifiers

PMID35077453
PMCPMC8824365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.